Primecap Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
EAM
Primecap Management's GH Position: Q3 2025 in Review
Primecap Management sold out of Guardant Health (GH) in Q3 2025, closing a stake of 65,990 shares — an estimated $3.43M sold.
Primecap Management first reported a position in GH in Q3 2020 and held it in 20 quarters. The position peaked at $24.6M in Q3 2021. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.
- Primecap Management reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
- Primecap Management sold 65,990 Guardant Health shares in Q3 2025, an estimated $3.43M.
- Primecap Management first reported a position in Guardant Health in Q3 2020 and held it in 20 quarters.
- Primecap Management's Guardant Health position peaked at $24.6M in Q3 2021.
- 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.
Based on Primecap Management's 13F filing for Q3 2025, filed 12 Nov 2025.